MondegarAI
CM Management, LLC

Q2 2024 · 13F-HR

CM Management, LLCholdings as filed

Filed 2024-08-01 · accession 0001841857-24-000003

$109.0M
Reported value
63
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
876511106TGBTASEKO MINES LTD$6.0M5.51%2,450,000CommonSOLE
016230104ALCOALICO INC$5.8M5.35%225,000CommonSOLE
03152W109AM6AMICUS THERAPEUTICS INC$4.5M4.10%450,000CommonSOLE
75025X100RLGTRADIANT LOGISTICS INC$4.4M4.05%775,000CommonSOLE
G7709Q104RPRXROYALTY PHARMA PLC SHS$4.2M3.87%160,000CommonSOLE
65158N102NMRKNEWMARK GROUP INC$4.1M3.75%400,000CommonSOLE
50155Q100KDKYNDRYL HLDGS INC$3.7M3.38%140,000CommonSOLE
740444104PLPCPREFORMED LINE PRODS CO$3.2M2.97%26,000CommonSOLE
461147100INTTINTEST CORP$3.1M2.80%309,000CommonSOLE
041242108ARKOARKO CORP$2.9M2.67%1,020,000CommonSOLE
69553P100PDPAGERDUTY INC$2.8M2.52%120,000CommonSOLE
088929104BGCBGC GROUP INC$2.7M2.48%325,000CommonSOLE
040712101ARKRARK RESTAURANTS CORP$2.6M2.41%200,000CommonSOLE
056752108BIDUBAIDU INC$2.6M2.38%30,000CommonSOLE
68622V106OGNORGANON & CO$2.6M2.37%125,000CommonSOLE
87484T108TALOTALOS ENERGY INC$2.4M2.23%200,000CommonSOLE
01609W102BABAALIBABA GROUP HLDG LTD$2.2M1.98%30,000CommonSOLE
92556V106VTRSVIATRIS INC$2.1M1.95%200,000CommonSOLE
067901108ABXBARRICK GOLD CORP$2.1M1.91%125,000CommonSOLE
18507C103CLPTCLEARPOINT NEURO INC$2.0M1.85%375,000CommonSOLE
152006102CGAUCENTERRA GOLD INC$2.0M1.85%300,000CommonSOLE
462260100IOVAIOVANCE BIOTHERAPEUTICS INC$2.0M1.84%250,000CommonSOLE
19249H103CHRSCOHERUS BIOSCIENCES INC$1.9M1.75%1,100,000CommonSOLE
760281204RBCAAREPUBLIC BANCORP KY$1.9M1.72%35,000CommonSOLE
931427108WFCWALGREENS BOOTS ALLIANCE INC$1.8M1.66%150,000CommonSOLE
126650100CVSCVS HEALTH CORP$1.8M1.63%30,000CommonSOLE
30052C107EOLSEVOLUS INC$1.6M1.49%150,000CommonSOLE
78573M104SABRSABRE CORP$1.6M1.47%600,000CommonSOLE
11373M107BB3BROOKLINE BANCORP INC DEL$1.6M1.46%190,000CommonSOLE
81761L102SVCSERVICE PPTYS TR$1.5M1.41%300,000CommonSOLE
697900108PAASPAN AMERN SILVER CORP$1.5M1.37%75,000CommonSOLE
934423104WBDWARNER BROS DISCOVERY INC$1.5M1.37%200,000CommonSOLE
320218100THFFFIRST FINL CORP IND$1.5M1.35%40,000CommonSOLE
717081103PFEPFIZER INC$1.4M1.28%50,000CommonSOLE
G50871105JAZZJAZZ PHARMACEUTICALS PLC$1.3M1.22%12,500CommonSOLE
98419J206XOMAXOMA CORP DEL$1.3M1.20%55,000CommonSOLE
02341Q205DITAMCON DISTRG CO$1.2M1.06%8,200CommonSOLE
651229106NWLNEWELL BRANDS INC$1.1M1.03%175,000CommonSOLE
427746102HRTXHERON THERAPEUTICS INC$1.1M0.96%300,000CommonSOLE
761330109RVNCEURREVANCE THERAPEUTICS INC$1.0M0.94%400,000CommonSOLE
192576106COHUCOHU INC$993,0000.91%30,000CommonSOLE
640268108NKTREURNEKTAR THERAPEUTICS$930,0000.85%750,000CommonSOLE
04683R106AVIRATEA PHARMACEUTICALS INC$893,7000.82%270,000CommonSOLE
418056107HASHASBRO INC$877,5000.81%15,000CommonSOLE
231269309CRISCURIS INC$828,0000.76%120,000CommonSOLE
500754106KHCKRAFT HEINZ CO$805,5000.74%25,000CommonSOLE
700517105PKPARK HOTELS RESORTS INC$749,0000.69%50,000CommonSOLE
004225108ACADACADIA PHARMACEUTICALS INC$650,0000.60%40,000CommonSOLE
22407B108COYACOYA THERAPEUTICS INC$606,0000.56%100,000CommonSOLE
23283X206CTSOCYTOSORBENTS CORP$597,5500.55%850,000CommonSOLE
925050106VRNAVERONA PHARMA PLC$506,1000.46%35,000CommonSOLE
31447E105FEMYFEMASYS INC$484,5000.44%425,000CommonSOLE
07134L107BATLBATTALION OIL CORP$467,6000.43%140,000CommonSOLE
04546C205ASSERTIO HOLDINGS INC$434,0000.40%350,000CommonSOLE
28617K101ELDNELEDON PHARMACEUTICALS INC$422,4000.39%160,000CommonSOLE
27966L306EDSAEDESA BIOTECH INC$385,2000.35%90,000CommonSOLE
51654W101LTRNLANTERN PHARMA INC$373,6000.34%80,000CommonSOLE
19243B102CGTXCOGNITION THERAPEUTICS INC$332,0000.30%200,000CommonSOLE
20454B104CMPXCOMPASS THERAPEUTICS INC$310,0000.28%310,000CommonSOLE
12740C103CADECADENCE BANK$282,8000.26%10,000CommonSOLE
28657F103ELTXELICIO THERAPEUTICS INC$205,5000.19%50,000CommonSOLE
50107A104KRON1USDKRONOS BIO INC$167,4000.15%135,000CommonSOLE
36269B105GANXGAIN THERAPEUTICS INC$115,2000.11%90,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.